Lineage Cell Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Lineage Cell Therapeutics Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Lineage Cell Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Lineage Cell Therapeutics Inc.

Back to companies

Lineage Cell Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Lineage Cell Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Lineage Cell Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Michael H. Mulroy

Chairman Executive Board Since: 2024 Age: 59

Mr. Michael H. Mulroy has been the Chairman of the company since 2024. Prior to this, he served as the Chief Executive Officer and Director of Asterias Biotherapeutics Inc. Previously, he served as the Diector of Magtrol Inc. Mr. Mulroy also served as the Senior Advisor to CamberView Partners LLC.

Read Hide full bio of Michael H. Mulroy

Brian M. Culley

Chief Executive Officer; Director Executive Board Since: 2018 Age: 53

Mr. Brian M. Culley has been the Chief Executive Officer and Director of the company since 2018. Prior to this, he served as the Interm Chief Executive Officer at Artemis Therapeutics. Previously, he served as the Chief Executive Officer of Mast Therapeutics. Mr. Culley also served as the Chief Business Officer and Senior Vice President of Business Development at Mast Therapeutics. Before that, he served as the Director of Business Development and Marketing at Immusol.

Read Hide full bio of Brian M. Culley

Jill A. Howe

Chief Financial Officer Senior Management Since: 2022 Age: 49

Ms. Jill A. Howe has been the Chief Financial Officer of the company since 2022. Prior to this, she served as the Chief Financial Officer at DTx Pharma from 2021 to 2022. Previously, she served as the Vice President of Finance and Treasury at Gossamer Bio from 2018 to 2021. Ms. Howe also served as the Controller and Director of Finance at Receptos from 2013 to 2016.

Read Hide full bio of Jill A. Howe

Rami Skaliter, Ph.D.

Chief Executive Officer - Cell Cure Neurosciences Senior Management Since: 2017

Michael Lauw

Vice President - Clinical Development Senior Management Since: 2024
Gain a 360-degree view of Lineage Cell Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Lineage Cell Therapeutics Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer